Semaglutide and the risk of adverse liver outcomes in patients with nonalcoholic fatty liver disease and type 2 diabetes: a multi-institutional cohort study
While you can't get a Retatrutide prescription today, knowing its potential impact is important as you explore options in medical weight loss in Wausau
These medications act on GLP-1 and GIP receptors located throughout the body, not just in the digestive system
For all of these agents, there will ultimately be interest in knowing their effect on cardiovascular events. For their active comparatorcontrolled, double-blind, noninferiority trial that began in 2020, 6,586 patients with type 2 diabetes were randomized to a tirzepatide (dual glucose-dependent insulinotropic polypeptide [GIP]/GLP-1RA) treatment group and 6,579 to a dulaglutide (selective GLP-1RA) group and followed for four years
Targets and mechanisms of sulforaphane derivatives obtained from cruciferous plants with special focus on breast cancercontradictory effects and future perspectives